Apogee Therapeutics Inc (APGE)

Jul 22, 2025

Is Apogee Therapeutics Inc. a good long term investmentOutstanding capital returns - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

What drives Apogee Therapeutics Inc. stock priceExtraordinary earning power - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Apogee Therapeutics Inc. Stock Analysis and ForecastFastest-growing stock picks - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

What analysts say about Apogee Therapeutics Inc. stockTremendous growth potential - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

InvestingPro Fair Value model captures 43% downside in Apogee Therapeutics By Investing.com - Investing.com Canada

Jul 22, 2025

Jul 20, 2025

Teacher Retirement System of Texas Sells 629 Shares of Apogee Therapeutics Inc. (NASDAQ:APGE) - Defense World

Jul 20, 2025

Jul 19, 2025

BTIG Raises PT on Apogee Therapeutics (APGE) to $115 From $100, Keeps a Buy Rating - MSN

Jul 19, 2025

Jul 18, 2025

Will Apogee Therapeutics Inc. stock benefit from interest rate changesTop Gaining Low Risk Assets - Newser

Jul 18, 2025

Jul 17, 2025

12 Oversold NASDAQ Stocks to Buy Now - Insider Monkey

Jul 17, 2025

Jul 15, 2025

Apogee Therapeutics (APGE) Falls 17%, Positive Trial Results Fail to Impress Investors - MSN

Jul 15, 2025

Jul 15, 2025

What makes Apogee Therapeutics Inc. stock price move sharplyFree Stock Selection - Newser

Jul 15, 2025

Jul 15, 2025

Why Apogee Therapeutics Inc. stock attracts strong analyst attentionLow Risk Stock Strategies - Newser

Jul 15, 2025

Jul 15, 2025

How Apogee Therapeutics Inc. stock performs during market volatilityStable Growth Stock Picks - Newser

Jul 15, 2025

Jul 14, 2025

Canaccord Genuity Reiterated a Buy Rating on Apogee Therapeutics (APGE) - Insider Monkey

Jul 14, 2025

Jul 14, 2025

Analysts Set Apogee Therapeutics Inc. (NASDAQ:APGE) Price Target at $99.00 - Defense World

Jul 14, 2025

Jul 11, 2025

Rx Rundown: Merck, Gilead Sciences, Apogee Therapeutics and more - Medical Marketing and Media

Jul 11, 2025

Jul 10, 2025

Stifel reiterates Buy rating on Apogee Therapeutics stock amid positive AD data - Investing.com Nigeria

Jul 10, 2025

Jul 10, 2025

Trend Tracker for (APGE) - news.stocktradersdaily.com

Jul 10, 2025

Jul 08, 2025

Apogee falls after results from atopic dermatitis trial - MSN

Jul 08, 2025

Jul 08, 2025

Canaccord Genuity reaffirms Buy rating on Apogee Therapeutics stock after positive trial data - Investing.com Canada

Jul 08, 2025

Jul 08, 2025

Apogee Therapeutics: Funding Supports Best-In-Class Ambitions In Atopic Dermatitis (APGE) - Seeking Alpha

Jul 08, 2025

Jul 08, 2025

Gold Falls 1%; ProKidney Shares Spike HigherApogee Therapeutics (NASDAQ:APGE), Blue Gold (NASDAQ:BGL) - Benzinga

Jul 08, 2025

Jul 08, 2025

Canaccord Genuity reaffirms Buy rating on Apogee Therapeutics stock after positive trial data By Investing.com - Investing.com South Africa

Jul 08, 2025

Jul 08, 2025

Jefferies raises Apogee Therapeutics stock price target to $96 on promising trial data - Investing.com Nigeria

Jul 08, 2025

Jul 08, 2025

Jefferies raises Apogee Therapeutics stock price target to $96 on promising trial data By Investing.com - Investing.com South Africa

Jul 08, 2025

Jul 08, 2025

Apogee Therapeutics shares fall 1.66% in premarket after profit-taking and technical selling. - AInvest

Jul 08, 2025

Jul 08, 2025

Positive Phase II APEX clinical trial of Apogee’s APG777 - The Pharma Letter

Jul 08, 2025

Jul 08, 2025

Apogee Therapeutics’ (APGE) Outperform Rating Reaffirmed at Wedbush - Defense World

Jul 08, 2025

Jul 08, 2025

Apogee Therapeutics Target of Unusually Large Options Trading (NASDAQ:APGE) - Defense World

Jul 08, 2025

Jul 07, 2025

Apogee Therapeutics stock maintains Buy rating at Citi after positive data - Investing.com India

Jul 07, 2025

Jul 07, 2025

Apogee Therapeutics stock maintains Buy rating at Citi after positive data By Investing.com - Investing.com South Africa

Jul 07, 2025